EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is the exclusive partner of the European Molecular Biology Laboratory (EMBL) for technology transfer.

Currently, EMBLEM manages a portfolio of more than two hundred and fifty patents/copyrights and over four hundred license contracts. Our technology portfolio spans the Life Sciences in the broadest sense and includes enabling technologies, molecular tools & techniques, instruments & devices as well as software programmes & databases.

Please feel free to browse our site to discover how our technology portfolio may be of use to you.